EP 3883557 A1 20210929 - COMPOSITION FOR USE IN THE PREVENTION AND/OR SYMPTOMATIC TREATMENT OF IRRITABLE BOWEL SYNDROME
Title (en)
COMPOSITION FOR USE IN THE PREVENTION AND/OR SYMPTOMATIC TREATMENT OF IRRITABLE BOWEL SYNDROME
Title (de)
ZUSAMMENSETZUNG ZUR VERWENDUNG BEI DER PRÄVENTION UND/ODER SYMPTOMATISCHEN BEHANDLUNG DES REIZDARMSYNDROMS
Title (fr)
COMPOSITION DESTINÉE À ÊTRE UTILISÉE DANS LA PRÉVENTION ET/OU LE TRAITEMENT SYMPTOMATIQUE DU SYNDROME DU CÔLON IRRITABLE
Publication
Application
Priority
- IT 201800010473 A 20181121
- IB 2019060029 W 20191121
Abstract (en)
[origin: WO2020104987A1] A synergistic composition of naturally occurring active ingredients is described, which has proved particularly effective in the treatment and/or prevention of irritable bowel syndrome. The composition of the invention includes the synergistic combination of butyric acid or a salt thereof and Tamarindus indica extract.
IPC 8 full level
A61K 31/19 (2006.01); A61K 9/00 (2006.01); A61K 36/00 (2006.01); A61P 1/00 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP US)
A61K 9/0053 (2013.01 - EP); A61K 31/19 (2013.01 - EP US); A61K 36/48 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP)
C-Set (source: EP)
Citation (search report)
See references of WO 2020104987A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020104987 A1 20200528; EP 3883557 A1 20210929; IT 201800010473 A1 20200521; US 2022008494 A1 20220113
DOCDB simple family (application)
IB 2019060029 W 20191121; EP 19829678 A 20191121; IT 201800010473 A 20181121; US 201817295679 A 20181121